| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1525-139X.2000.00011.X |
| P698 | PubMed publication ID | 10740670 |
| P2093 | author name string | Johnson CA | |
| P2860 | cites work | Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial | Q34182887 |
| Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years | Q37610123 | ||
| Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial | Q41646726 | ||
| Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma | Q42230474 | ||
| Effects of androgen therapy on prostatic markers in hemodialyzed patients | Q42520994 | ||
| Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease | Q43529741 | ||
| Erythropoiesis and Erythropoietin in Patients with Chronic Renal Failure Treated with Hemodialysis and Testosterone | Q43622361 | ||
| Erythropoietic response of dialyzed patients to testosterone administration | Q47658480 | ||
| Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era. | Q50989339 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 36-39 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Seminars in Dialysis | Q15761546 |
| P1476 | title | Use of androgens in patients with renal failure | |
| P478 | volume | 13 |
| Q36809862 | An update on nutrition in chronic kidney disease |
| Q38587545 | Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. |
| Q24803599 | Effect of Nandrolone Decanoate on serum lipoprotein (a) and its isoforms in hemodialysis patients |
| Q38944393 | Gonadal dysfunction in chronic kidney disease |
| Q34213881 | Growth factors in the treatment of wasting in kidney failure |
| Q36344091 | Meta-Analysis of Randomized Controlled Trials on Androgens versus Erythropoietin for Anaemia of Chronic Kidney Disease: Implications for Developing Countries. |
| Q35207564 | Pharmacoeconomic considerations in the health system management of anaemia in patients with chronic kidney disease and end stage renal disease |
| Q64885970 | The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. |
Search more.